Treatment of Diabetes After Gastric Bypass With Sitagliptin
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether Januvia (sitagliptin phosphate 100mg) is safe
and effective for the treatment of Type 2 Diabetes in patients who have had Gastric Bypass.